(Q40308181)

19 September 2017

title

HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. (English)

1 reference

19 September 2017

8

Ingeborg Zehbe

1 reference

19 September 2017

Hava Lichtig

1

1 reference

19 September 2017

Meirav Algrisi

2

1 reference

19 September 2017

Liat Edri Botzer

3

1 reference

19 September 2017

Tal Abadi

4

1 reference

19 September 2017

Yulia Verbitzky

5

1 reference

19 September 2017

Anna Jackman

6

1 reference

19 September 2017

Massimo Tommasino

7

1 reference

19 September 2017

Levana Sherman

9

1 reference

19 September 2017

language of work or name

English

0 references

publication date

6 March 2006

1 reference

19 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

19 September 2017

volume

350

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

216-227

1 reference

The epidemiology of human papillomavirus infections

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The Bcl2 family: regulators of the cellular life-or-death switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Persistent human papillomavirus infection and cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus variants and squamous neoplasia of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Molecular basis for heterogeneity of the human p53 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Host and viral genetics and risk of cervical cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The human papillomavirus E6 protein and its contribution to malignant progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus immortalization and transformation functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

A functional p53-responsive intronic promoter is contained within the human mdm2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.01.038

1 reference

19 September 2017

1 reference